Neuronal Vulnerability in Parkinson Disease and Putative Therapeutics: Should the focus be on axonal and synaptic terminals?

While current effective therapies are available for the symptomatic control of Parkinsońs disease (PD), treatments to halt the progressive neurodegeneration still do not exist. Loss of dopamine neurons in the substantia nigra pars compacta and dopamine terminals in the striatum drive the motor featu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord
Main Authors: Wong, Yvette, Luk, Kelvin, Purtell, Kerry, Nanni, Samuel Burke, Stoessl, A. Jon, Trudeau, Louis-Eric, Yue, Zhenyu, Krainc, Dimitri, Oertel, Wolfgang, Obeso, Jose A., Volpicelli-Daley, Laura
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879792/
https://ncbi.nlm.nih.gov/pubmed/31483900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27823
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados